Government Pharmaceutical Organization Maintains Production Amid Flood Crisis
The Government Pharmaceutical Organization (GPO) has confirmed that its three manufacturing plants remain fully operational to support flood relief efforts.
According to a report by Matichon Online on September 28, 2026, the Government Pharmaceutical Organization (GPO) has announced that its three drug manufacturing facilities are continuing operations as scheduled, despite the government declaring a public holiday.
This decision aims to ensure a steady supply of essential medications during the ongoing flood crisis affecting various regions of Thailand. The GPO confirmed that it has already expedited the distribution of 52,000 medical kits to assist flood-affected populations.
For residents and travelers, this update is significant as it indicates that the national supply chain for critical medicines remains stable despite the severe weather conditions. The continued operation of these plants helps mitigate the risk of drug shortages in areas impacted by flooding.
While the GPO has confirmed the current status of its production lines and the initial delivery of aid, the total scope of the medical requirements for the flood-affected areas remains to be fully assessed. Authorities have not yet specified how long these emergency production schedules will remain in effect or if further shifts in operations will be necessary as the flood situation evolves. Residents are advised to monitor official health announcements for updates on medical resource availability.
